Acute renal failure definitions and classification: Time for change?

Journal of the American Society of Nephrology

Volumn 14, Issue 8, 2003, Pages 2178-2187

  Mehta, Ravindra L ^a   Chertow, Glenn M ^b  

^a UCSD MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CREATININE; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; INULIN; LOOP DIURETIC AGENT; OSMOTIC DIURETIC AGENT; RADIOISOTOPE; SOMATOMEDIN C;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; DIALYSIS; DISEASE CLASSIFICATION; GLOMERULUS FILTRATION RATE; HUMAN; INTENSIVE CARE UNIT; KIDNEY PERFUSION; LIVER DISEASE; MEDICAL DECISION MAKING; MORTALITY; PANCREATITIS; PRIORITY JOURNAL; REVIEW; SEPSIS; TUBULAR DYSFUNCTION; URINE VOLUME;

EID: 0042844692     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000079042.13465.1A     Document Type: Review

References (93)

1. Behrend T, Miller SB: Acute renal failure in the cardiac care unit: Etiologies, outcomes, and prognostic factors. Kidney Int 56: 238-243, 1999
2. Bennett WM: Posttransplant acute renal failure. Ren Fail 19: 225-226, 1997
3. DuBose TD Jr, Warnock DG, Mehta RL, Bonventre JV, Hammerman MR, Molitoris BA, Paller MS, Siegel NJ, Scherbenske J, Striker GE: Acute renal failure in the 21st century: Recommendations for management and outcomes assessment. Am J Kidney Dis 29: 793-799, 1997
4. Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP: Renal failure in the ICU: Comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 62: 986-996, 2002
5. Metcalfe W, Simpson M, Khan IH, Prescott GJ, Simpson K, Smith WC, MacLeod AM: Acute renal failure requiring renal replacement therapy: Incidence and outcome. Q J Med 95: 579-583, 2002
6. Liaño F, Junco E, Pascual J, Madero R, Verde E: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int 66: S16-S24, 1998
7. Pruchnicki MC, Dasta JF: Acute renal failure in hospitalized patients: Part I. Ann Pharmacother 36: 1261-1267, 2002
8. Lieberthal W, Nigam SK: Acute renal failure. II. Experimental models of acute renal failure: Imperfect but indispensable. Am J Physiol Renal Physiol 278: F1-F12, 2000
9. Rosen S, Heyman SN: Difficulties in understanding human "acute tubular necrosis": Limited data and flawed animal models. Kidney Int 60: 1220-1224, 2001
10. Ueda N, Kaushal GP, Shah SV: Apoptotic mechanisms in acute renal failure. Am J Med 108: 403-415, 2000
11. Heyman SN, Lieberthal W, Rogiers P, Bonventre JV: Animal models of acute tubular necrosis. Curr Opin Crit Care 8: 526-534, 2002
12. Sutton TA, Fisher CJ, Molitoris BA: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62: 1539-1549, 2002
13. Wang S, Hirschberg R: Role of growth factors in acute renal failure. Nephrol Dial Transplant 12: 1560-1563, 1997
14. Meyer M, Richter R, Forssmann WG: Urodilatin, a natriuretic peptide with clinical implications. Eur J Med Res 3: 103-110, 1998
15. Lieberthal W: Biology of ischemic and toxic renal tubular cell injury: Role of nitric oxide and the inflammatory response. Curr Opin Nephrol Hypertens 7: 289-295, 1998
16. Block CA, Manning HL: Prevention of acute renal failure in the critically ill. Am J Respir Crit Care Med 165: 320-324, 2002
17. Holt SG, Moore KP: Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med 27: 803-811, 2001
18. Star RA: Treatment of acute renal failure. Kidney Int 54: 1817-1831, 1998
19. Kelly KJ, Molitoris BA: Acute renal failure in the new millennium: Time to consider combination therapy. Semin Nephrol 20: 4-19, 2000
20. Ronco C, Bellomo R, Ricci Z: Continuous renal replacement therapy in critically ill patients, Nephrol Dial Transplant 16[Suppl 5]:67-72, 2001
21. Bellomo R, Kellum JA, Mehta R, Palevsky PM, Ronco C: Acute Dialysis Quality Initiative II: The Vicenza Conference, Curr Opin Crit Care 8: 505-508, 2002
22. Tonelli M, Manns B, Feller-Kopman D: Acute renal failure in the intensive care unit: A systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40: 875-885, 2002
23. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT: Hospital-acquired renal insufficiency: A prospective study, Am J Med 74: 243-248, 1983
24. Shusterman N, Strom BL, Murray TG, Morrison G, West SL, Maislin G: Risk factors and outcome of hospital-acquired acute renal failure. Am J Med 83: 65-71, 1987
25. Silvester W, Bellomo R, Cole L: Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 29: 1910-1915, 2001
26. Vincent JL: Incidence of acute renal failure in the intensive care unit. Contrib Nephrol 1-6, 2001
27. Liaño F, Pascual J: Outcomes in acute renal failure. Semin Nephrol 18: 541-550, 1998
28. Abernethy VE, Lieberthal W: Acute renal failure in the critically ill patient. Crit Care Clin 18: 203-222, 2002
29. Bates DW, Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, Platt R: Correlates of acute renal failure in patients receiving parenteral amphotericin B. Kidney Int 60: 1452-1459, 2001
30. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ: Acute renal failure in intensive care units: Causes, outcome, and prognostic factors of hospital mortality - A prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 24: 192-198, 1996
31. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ: Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA 283: 2686-2692, 2000
32. Lincoff AM, Tcheng JE, Califf RM, Kereiakes DJ, Kelly TA, Timmis GC, Kleiman NS, Booth JE, Balog C, Cabot CF, Anderson KM, Weisman HF, Topol EJ: Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: One-year outcome in the EPILOG trial. Evaluation in PTCA to improve long-term outcome with abciximab GP IIb/IIIa blockade. Circulation 99: 1951-1958, 1999
33. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, Brodie BR, Madonna O, Eijgelshoven M, Lansky AJ, O'Neill WW, Morice, MC: Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 341: 1949-1956, 1999
34. Canto JG, Every NR, Magid DJ, Rogers WJ, Malmgren JA, Frederick PD, French WJ, Tiefenbrunn AJ, Misra VK, Kiefe CI, Barron HV: The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med 342: 1573-1580, 2000
35. Venkataram R, Kellum JA: The role of diuretic agents in the management of acute renal failure. Contrib Nephrol 158-170, 2001
36. Solomon R, Werner C, Mann D, D'Elia J, Silva P: Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331: 1416-1420, 1994
37. Kellum JA, Decker JM: Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 29: 1526-1531, 2001
38. Denton MD, Chertow GM, Brady HR: "Renal-dose" dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials, Kidney Int 50: 4-14, 1996
39. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH: Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336: 828-834, 1997
40. Lewis J, Salem MM, Chertow GM, Weisberg LS, McGrew F, Marbury TC, Allgren RL: Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 36: 767-774, 2000
41. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O'Shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W, et al.: Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 55: 2423-2432, 1999
42. Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N, Schwab SJ: Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 57: 1675-1680, 2000
43. Nash K, Hafeez A, Hou S: Hospital-acquired renal insufficiency. Am J Kidney Dis 39: 930-936, 2002
44. Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A, Kaplan RM: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60: 1154-1163, 2001
45. Albright RC Jr, Smelser JM, McCarthy JT, Homburger HA, Bergstralh EJ, Larson TS: Patient survival and renal recovery in acute renal failure: Randomized comparison of cellulose acetate and polysulfone membrane dialyzers. Mayo Clin Proc 75: 1141-1147, 2000
46. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P: Prognostic factors in acute renal failure due to sepsis: Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant 11: 293-299, 1996
47. Schor N: Acute renal failure and the sepsis syndrome. Kidney Int 61: 764-776, 2002
48. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality: A cohort analysis. JAMA 275: 1489-1494, 1996
49. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180-184, 2000
50. Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF: Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA 289: 553-558, 2003
51. Obialo CI, Crowell AK, Okonofua EC: Acute renal failure mortality in hospitalized African Americans: Age and gender considerations. J Natl Med Assoc 94: 127-134, 2002
52. Bates DW, Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, Dasbach EJ, Platt R: Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis 32: 686-693, 2001
53. Perrone RD, Madias NE, Levey AS: Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 38: 1933-1953, 1992
54. Mehta RL, McDonald B, Gabbai F, Pahl M, Farkas A, Pascual MT, Zhuang S, Kaplan RM, Chertow GM: Nephrology consultation in acute renal failure: Does timing matter? Am J Med 113: 456-461, 2002
55. Bone RC: Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268: 3452-3455, 1992
56. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E: Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334: 1697-1702, 1996
57. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709, 2001
58. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC: Prognostic signs and the role of the operative management in acute pancreatitis. Surg Gynecol Obstet 139: 69-81, 1974
59. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 649-649, 1973
60. Molitoris B, Dagher P, Herget-Rosenthal S, Ruehm S, Jo S, Star R, Agarwal R: Newly developed techniques to study acute renal failure: Understanding pathophysiology and therapy in humans. J Am Soc Nephrol, in press
61. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M: Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury, J Biol Chem 273: 4135, 1998
62. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV: Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 62: 237-244, 2002
63. Star R, Hostetter T, Hortin GL: New markers for kidney disease. Clin Chem 48: 1375-1376, 2002
64. Muramatsu Y, Tsujie M, Kohda Y, Pham B, Perantoni AO, Zhao H, Jo SK, Yuen PS, Craig L, Hu X, Star RA: Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int 62: 1601-1610, 2002
65. Westhuyzen J, Endre ZH, Reece G, Reith DM, Saltissi D, Morgan TJ: Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 18: 543-551, 2003
66. Bonventre J: The kidney proteome: A hint of things to come. Kidney Int 62: 1470-1471, 2002
67. Agarwal R: Chromatographic estimation of iothalamate and p-aminohippuric acid to measure glomerular filtration rate and effective renal plasma flow in humans. J Chromatogr B Biomed Sci Appl 705: 3-9, 1998
68. Hermeida J, Romero R, Tutor J: Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney and liver transplant recipients. Kidney Int 60: 1561-1564, 2001
69. Prasad PV, Priatna A, Spokes K, Epstein FH: Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy. J Magn Reson Imaging 13: 744-747, 2001
70. Kobayashi H, Kawamoto S, Jo SK, Sato N, Saga T, Hiraga A, Konishi J, Hu S, Togashi KM, Brechbiel M, Star R: Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent. Kidney Int 61: 1980, 1985, 2002
71. Jo S, Hu X, Kobayashi H, Lizak M, Miyaji T, Koretsky A, Star R: Detection of inflammation following renal ischemia by magnetic resonance imaging. Kidney Int 64:43-51, 2003
72. Guitterez NV, Diaz A, Timmis GC, O'Neill WW, Stevens MA, Sandberg KR, McCullough PA: Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol 15: 349-354, 2002
73. Moran SM, Myers BD: Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int 27: 928-937, 1985
74. Moran SM, Myers BD: Pathophysiology of protracted acute renal failure in man. J Clin Invest 76: 1440-1448, 1985
75. Myers BD, Moran SM: Hemodynamically mediated acute renal failure. N Engl J Med 314: 97-105, 1986
76. Pannu N, Mehta RL: Mechanical ventilation and renal function: An area for concern? Am J Kidney Dis 39: 616-624, 2002
77. Levy MM, Fink M, Marshall JC, Abraham E, Angus DC, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256, 2003
78. Kellum J, Levin N, Bouman C, Lameire N: Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 8: 509-514, 2002
79. Molitoris B: Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol 14: 265-267, 2003
80. Bonventre J: Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 11: 43-48, 2002
81. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, Bashore TM: Contrast nephrotoxicity: A randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320: 149-153, 1989
82. Weisberg LS, Kurnik PB, Kurnik BR: Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45: 259-265, 1994
83. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA, Timmis GC, O'Neill WW: A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the PRINCE Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 33: 403-411, 1999
84. Liaño F, Pascual J: Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 50: 811-818, 1996
85. Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS: Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31: 674-680, 1998
86. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: A prospective controlled study. N Engl J Med 320: 143-149, 1989
87. Cochran ST, Wong WS, Roe DJ: Predicting angiography-induced acute renal function impairment: Clinical risk model. AJR Am J Roentgenol 141: 1027-1033, 1983
88. Eisenberg RL, Bank WO, Hedgock MW: Renal failure after major angiography can be avoided with hydration. AJR Am J Roentgenol 136: 859-861, 1981
89. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, Lautin JL, Braha S, Kadish EG, Sprayregen S, et al.: Radiocontrast-associated renal dysfunction: Incidence and risk factors. AJR Am J Roentgenol 157: 49-58, 1991
90. Fiaccadori E, Lombardi M, Leonardi S, Rotelli CF, Tortorella G, Borghetti A: Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: A prospective cohort study. J Am Soc Nephrol 10: 581-593, 1999
91. Taylor AJ, Hotchkiss D, Morse RW, McCabe J: PREPARED: Preparation for angiography in renal dysfunction: A randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 114: 1570-1574, 1998
92. Mehta RL, Pascual MT, Gruta CG, Zhuang S, Chertow GM: Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol 13: 1350-1357, 2002
93. National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002